HBOT and Longevity: The Rising Healthy-Aging Trend

The longevity movement — brought into the mainstream by tech entrepreneurs like Bryan Johnson and their personal 'age-reversal' protocols — has also boosted interest in hyperbaric oxygen therapy. One of its scientific anchors is a clinical study published in the journal Aging in 2020, in which 35 healthy adults aged 64 and over completed a 60-session HBOT program.

The study reported telomere lengthening of more than 20% in immune cells — up to 37% in B cells — along with a reduction of up to 37% in senescent immune cells. Because the trial had no control group and a limited sample size, the results are considered 'promising but preliminary'; the researchers stress that larger studies are needed to define optimal protocols.

These posts are summaries compiled from publicly available scientific publications and news sources; they do not constitute medical advice. Always consult a healthcare professional for treatment decisions.
Source: PMC – HBOT Increases Telomere Length and Decreases Immunosenescence (Aging, 2020)